1. 안녕하십니까? Takeda제약(일본 최대 제약회사)에서 스핀아웃 되어 설립된 일본 최초의 신약솔루션 제공업체인Axcelead Drug Discovery Partners를 초대하여 정기 webinar를 개최합니다. 정기 webinar를 통하여 신약개발에 필요한 다양한 지식과 경험을 소개할 예정이오니, 여러분의 많은 참가를 기대합니다. 감사합니다.
2. 연자: Dr.Kiyoshi Takasuna, Director, Integrated Translational Research (Axcelead Drug Discovery Partners)
Safety-related drug attrition is still a major hurdle in the development of innovative pharmaceuticals. Therefore, an integrated safety assessment to identify On-/Off-target safety risk and de-risk the toxicity at an early drug discovery phase is an essential part of successful drug development.
We Axcelead DDP can offer an ideal safety assessment strategy, mechanism-based and cost-effective solutions with high-quality and fast turnaround times, depending on your requirements and stage of your project. In this seminar, we will present our unique in vitro safety assessment services and risk mitigation solutions.